BridgeMD
New treatment option for Severe Infection
Official title Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model
ClinicalTrials.gov ID: NCT06161870
What this study is testing
What is individualized vancomycin dosing based on the population pharmacokinetics (PK) model?
individualized vancomycin dosing based on the population pharmacokinetics (PK) model is an investigational medicine, being studied as a potential treatment for severe infection.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to compare the clinical efficacy of individualized dosing based on the population pharmacokinetics (PK) model and empirical dosing of vancomycin in participants with severe infections. It aims to answer whether individual vancomycin dosing based on population PK model is superior to empirical dosing in terms of clinical efficacy and safety.
- Phase 4: studies an already-approved treatment
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Admission to neurological intensive care unit (NICU).
- Age ≥18 years old. Participants will be eligible if they meet both of these criteria.
You likely can't join if
- Evidence of absolute renal impairment, which included Serum creatinine (SCR) ≥133 μmol/L at admission, development of acute kidney injury (AKI) after...
- Pregnant participants.
- Primary diagnosis is non-neurological disease.
- The height or weight of participants is not recorded in the medical record system.
- The frequency of SCR monitoring was less than 3 times. Participants who meet any of these criteria will be excluded.
The study team makes the final eligibility decision.
Where it's taking place
- Changsha, Hunan, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Changsha, Hunan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.